Institute News: Awards & Honors

National Academy of Sciences honors cognitive neuroscientist Nancy Kanwisher

by Julie Pryor |

MIT neuroscientist and McGovern Investigator Nancy Kanwisher. Photo: Jussi Puikkonen/KNAW

The National Academy of Sciences (NAS) has announced today that Nancy Kanwisher, the Walter A. Rosenblith Professor of Cognitive Neuroscience in MIT’s Department of Brain and Cognitive Sciences, has received the 2022 NAS Award in the Neurosciences for her “pioneering research into the functional organization of the human brain.” The $25,000 prize, established by the Fidia Research Foundation, is presented every three years to recognize “extraordinary contributions to the neuroscience fields.”

“I am deeply honored to receive this award from the NAS,” says Kanwisher, who is also an investigator in MIT’s McGovern Institute and a member of the Center for Brains, Minds and Machines. “It has been a profound privilege, and a total blast, to watch the human brain in action as these data began to reveal an initial picture of the organization of the human mind. But the biggest joy has been the opportunity to work with the incredible group of talented young scientists who actually did the work that this award recognizes.”

A window into the mind

Kanwisher is best known for her landmark insights into how humans recognize and process faces. Psychology had long-suggested that recognizing a face might be distinct from general object recognition. But Kanwisher galvanized the field in 1997 with her seminal discovery that the human brain contains a small region specialized to respond only to faces. The region, which Kanwisher termed the fusiform face area (FFA), became activated when subjects viewed images of faces in an MRI scanner, but not when they looked at scrambled faces or control stimuli.

Since her 1997 discovery (now the most highly cited manuscript in its area), Kanwisher and her students have applied similar methods to find brain specializations for the recognition of scenes, the mental states of others, language, and music. Taken together, her research provides a compelling glimpse into the architecture of the brain, and, ultimately, what makes us human.

“Nancy’s work over the past two decades has argued that many aspects of human cognition are supported by specialized neural circuitry, a conclusion that stands in contrast to our subjective sense of a singular mental experience,” says McGovern Institute Director Robert Desimone. “She has made profound contributions to the psychological and cognitive sciences and I am delighted that the National Academy of Sciences has recognized her outstanding achievements.”

One-in-a-million mentor

Beyond the lab, Kanwisher has a reputation as a tireless communicator and mentor who is actively engaged in the policy implications of brain research. The statistics speak for themselves: her 2014 TED talk, “A Neural portrait of the human mind” has been viewed over a million times online and her introductory MIT OCW course on the human brain has generated more than nine million views on YouTube.

Nancy Kanwisher works with researchers from her lab in MIT’s Martinos Imaging Center. Photo: Kris Brewer

Kanwisher also has an exceptional track record in training women scientists who have gone on to successful independent research careers, in many cases becoming prominent figures in their own right.

“Nancy is the one-in-a-million mentor, who is always skeptical of your ideas and your arguments, but immensely confident of your worth,” says Rebecca Saxe, John W. Jarve (1978) Professor of Brain and Cognitive Sciences, investigator at the McGovern Institute, and associate dean of MIT’s School of Science. Saxe was a graduate student in Kanwisher’s lab where she earned her PhD in cognitive neuroscience in 2003. “She has such authentic curiosity,” Saxe adds. “It’s infectious and sustaining. Working with Nancy was a constant reminder of why I wanted to be a scientist.”

The NAS will present Kanwisher with the award during its annual meeting on May 1, 2022 in Washington, DC. The event will be webcast live. Kanwisher plans to direct her prize funds to the non-profit organization Malengo, established by a former student and which provides quality undergraduate education to individuals who would otherwise not be able to afford it.

McGovern Institute Director receives highest honor from the Society for Neuroscience

by Julie Pryor |

The Society for Neuroscience will present its highest honor, the Ralph W. Gerard Prize in Neuroscience, to McGovern Institute Director Robert Desimone at its annual meeting today.

The Gerard Prize is named for neuroscientist Ralph W. Gerard who helped establish the Society for Neuroscience, and honors “outstanding scientists who have made significant contributions to neuroscience throughout their careers.” Desimone will share the $30,000 prize with Vanderbilt University neuroscientist Jon Kaas.

Desimone is being recognized for his career contributions to understanding cortical function in the visual system. His seminal work on attention spans decades, including the discovery of a neural basis for covert attention in the temporal cortex and the creation of the biased competition model, suggesting that attention is biased towards material relevant to the task. More recent work revealed how synchronized brain rhythms help enhance visual processing. Desimone also helped discover both face cells and neural populations that identify objects even when the size or location of the object changes. His long list of contributions includes mapping the extrastriate visual cortex, publishing the first report of columns for motion processing outside the primary visual cortex, and discovering how the temporal cortex retains memories. Desimone’s work has moved the field from broad strokes of input and output to a more nuanced understanding of cortical function that allows the brain to make sense of the environment.

At its annual meeting, beginning today, the Society will honor Desimone and other leading researchers who have made significant contributions to neuroscience — including the understanding of cognitive processes, drug addiction, neuropharmacology, and theoretical models — with this year’s Outstanding Achievement Awards.

“The Society is honored to recognize this year’s awardees, whose groundbreaking research has revolutionized our understanding of the brain, from the level of the synapse to the structure and function of the cortex, shedding light on how vision, memory, perception of touch and pain, and drug
addiction are organized in the brain,” SfN President Barry Everitt, said. “This exceptional group of neuroscientists has made fundamental discoveries, paved the way for new therapeutic approaches, and introduced new tools that will lay the foundation for decades of research to come.”

Five with MIT ties elected to the National Academy of Medicine for 2021

by Julie Pryor |

The National Academy of Medicine (NAM) has announced the election of 100 new members for 2021, including two MIT faculty members and three additional Institute affiliates.

Faculty honorees include Linda G. Griffith, a professor in the MIT departments of Biological Engineering and Mechanical Engineering; and Feng Zhang, a professor in the MIT departments of Brain and Cognitive Sciences and Biological Engineering. Guillermo Antonio Ameer SCD ’99, a professor of biomedical engineering and surgery at Northwestern University; Darrell Gaskin SM ’87, a professor of health policy and management at Johns Hopkins University; and Vamsi Mootha, an institute member of the Broad Institute of MIT and Harvard and former student in the Harvard-MIT Program in Health Sciences and Technology, were also honored.

The new inductees were elected through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. Election to the academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Griffith, the School of Engineering Professor of Teaching Innovation and director of the Center for Gynepathology Research at MIT, is credited for her longstanding leadership in research, education, and medical translation. Specifically, the NAM recognizes her pioneering work in tissue engineering, biomaterials, and systems biology, including the development of the first “liver chip” technology. Griffith is also recognized for inventing 3D biomaterials printing and organotypic models for systems gynopathology, and for the establishment of the biological engineering department at MIT.

The academy recognizes Zhang, the Patricia and James Poitras ’63 Professor in Neuroscience at MIT, for revolutionizing molecular biology and powering transformative leaps forward in our ability to study and treat human diseases. Zhang, who also is an investigator at the Howard Hughes Medical Institute and the McGovern Institute for Brain Research, and a core member of the Broad Institute of MIT and Harvard, is specifically credited for the discovery of novel microbial enzymes and their development as molecular technologies, including optogenetics and CRISPR-mediated genome editing. The academy also commends Zhang for his outstanding mentoring and professional services.

Ameer, the Daniel Hale Williams Professor of Biomedical Engineering and Surgery at the Northwestern University Feinberg School of Medicine, earned his Doctor of Science degree from the MIT Department of Chemical Engineering in 1999. A professor of biomedical engineering and of surgery who is also the director of the Center for Advanced Regenerative Engineering, he is cited by the NAM “For pioneering contributions to regenerative engineering and medicine through the development, dissemination, and translation of citrate-based biomaterials, a new class of biodegradable polymers that enabled the commercialization of innovative medical devices approved by the U.S. Food and Drug Administration for use in a variety of surgical procedures.”

Gaskin, the William C. and Nancy F. Richardson Professor in Health Policy and Management, Bloomberg School of Public Health at Johns Hopkins University, earned his Master of Science degree from the MIT Department of Economics in 1987. A health economist who advances community, neighborhood, and market-level policies and programs that reduce health disparities, he is cited by the NAM “For his work as a leading health economist and health services researcher who has advanced fundamental understanding of the role of place as a driver in racial and ethnic health disparities.”

Mootha, the founding co-director of the Broad Institute’s Metabolism Program, is a professor of systems biology and medicine at Harvard Medical School and a professor in the Department of Molecular Biology at Massachusetts General Hospital. An alumnus of the Harvard-MIT Program in Health Sciences and Technology and former postdoc with the Whitehead Institute for Biomedical Research, Mootha is an expert in the mitochondrion, the “powerhouse of the cell,” and its role in human disease. The NAM cites Mootha “For transforming the field of mitochondrial biology by creatively combining modern genomics with classical bioenergetics.”

Established in 1970 by the National Academy of Sciences, the NAM addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors. NAM works alongside the National Academy of Sciences and National Academy of Engineering to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies of Sciences, Engineering, and Medicine also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding of STEMM. With their election, NAM members make a commitment to volunteer their service in National Academies activities.

Seven from MIT receive National Institutes of Health awards

by MIT School of Science |

On Oct. 5, the National Institutes of Health announced the names of 106 scientists who have been awarded grants through the High-Risk, High-Reward Research program to advance highly innovative biomedical and behavioral research. Seven of the recipients are MIT faculty members.

The High-Risk, High-Reward Research program catalyzes scientific discovery by supporting research proposals that, due to their inherent risk, may struggle in the traditional peer-review process despite their transformative potential. Program applicants are encouraged to pursue trailblazing ideas in any area of research relevant to the NIH’s mission to advance knowledge and enhance health.

“The science put forward by this cohort is exceptionally novel and creative and is sure to push at the boundaries of what is known,” says NIH Director Francis S. Collins. “These visionary investigators come from a wide breadth of career stages and show that groundbreaking science can happen at any career level given the right opportunity.”

New innovators

Four MIT researchers received New Innovator Awards, which recognize “unusually innovative research from early career investigators.” They are:

  • Pulin Li is a member at the Whitehead Institute for Biomedical Research and an assistant professor in the Department of Biology. Li combines approaches from synthetic biology, developmental biology, biophysics and systems biology to quantitatively understand the genetic circuits underlying cell-cell communication that creates multicellular behaviors.
  • Seychelle Vos, the Robert A. Swanson (1969) Career Development Professor of Life Sciences in the Department of Biology, studies the interplay of gene expression and genome organization. Her work focuses on understanding how large molecular machineries involved in genome organization and gene transcription regulate each others’ function to ultimately determine cell fate and identity.
  • Xiao Wang, the Thomas D. and Virginia Cabot Assistant Professor of Chemistry and a member of the Broad Institute of MIT and Harvard, aims to develop high-resolution and highly-multiplexed molecular imaging methods across multiple scales toward understanding the physical and chemical basis of brain wiring and function.
  • Alison Wendlandt is a Cecil and Ida Green Career Development Assistant Professor of Chemistry. Wendlandt focuses on the development of selective, catalytic reactions using the tools of organic and organometallic synthesis and physical organic chemistry. Mechanistic study plays a central role in the development of these new transformations.

Transformative researchers

Two MIT researchers have received Transformative Research Awards, which “promote cross-cutting, interdisciplinary approaches that could potentially create or challenge existing paradigms.” The recipients are:

  • Manolis Kellis is a professor of computer science at MIT in the area of computational biology, an associate member of the Broad Institute, and a principal investigator with MIT’s Computer Science and Artificial Intelligence Laboratory. He aims to further our understanding of the human genome by computational integration of large-scale functional and comparative genomics datasets.
  • Myriam Heiman is the Latham Family Career Development Associate Professor of Neuroscience in the Department of Brain and Cognitive Sciences and an investigator in the Picower Institute for Learning and Memory. Heiman studies the selective vulnerability and pathophysiology seen in two neurodegenerative diseases of the basal ganglia, Huntington’s disease, and Parkinson’s disease.

Together, Heiman, Kellis and colleagues will launch a five-year investigation to pinpoint what may be going wrong in specific brain cells and to help identify new treatment approaches for amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with motor neuron disease (FTLD/MND). The project will bring together four labs, including Heiman and Kellis’ labs at MIT, to apply innovative techniques ranging from computational, genomic, and epigenomic analyses of cells from a rich sample of central nervous system tissue, to precision genetic engineering of stem cells and animal models.

Pioneering researchers

  • Polina Anikeeva received a Pioneer Award, which “challenges investigators at all career levels to pursue new research directions and develop groundbreaking, high-impact approaches to a broad area of biomedical, behavioral, or social science.” Anikeeva is an MIT professor of materials science and engineering, a professor of brain and cognitive sciences, and a McGovern Institute for Brain Research associate investigator. She has established a research program that uniquely combines materials synthesis, device fabrication, neurophysiology, and animal models of behavior. Her group carries out projects that understand, invent, and design materials from the level of atoms to functional devices with applications in fundamental neuroscience.

The program is supported by the NIH Common Fund, which oversees programs that pursue major opportunities and gaps throughout the research enterprise that are of great importance to NIH and require collaboration across the agency to succeed. It issues four awards each year: the Pioneer Award, the New Innovator Award, the Transformative Research Award, and the Early Independence Award.

This year, NIH issued 10 Pioneer awards, 64 New Innovator awards, 19 Transformative Research awards (10 general, four ALS-related, and five Covid-19-related), and 13 Early Independence awards for 2021. Funding for the awards comes from the NIH Common Fund, the National Institute of General Medical Sciences, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke.

Jacqueline Lees and Rebecca Saxe named associate deans of science

by Julia C. Keller | School of Science |

Jaqueline Lees and Rebecca Saxe have been named associate deans serving in the MIT School of Science. Lees is the Virginia and D.K. Ludwig Professor for Cancer Research and is currently the associate director of the Koch Institute for Integrative Cancer Research, as well as an associate department head and professor in the Department of Biology at MIT. Saxe is the John W. Jarve (1978) Professor in Brain and Cognitive Sciences and the associate head of the Department of Brain and Cognitive Sciences (BCS); she is also an associate investigator in the McGovern Institute for Brain Research.

Lees and Saxe will both contribute to the school’s diversity, equity, inclusion, and justice (DEIJ) activities, as well as develop and implement mentoring and other career-development programs to support the community. From their home departments, Saxe and Lees bring years of DEIJ and mentorship experience to bear on the expansion of school-level initiatives.

Lees currently serves on the dean’s science council in her capacity as associate director of the Koch Institute. In this new role as associate dean for the School of Science, she will bring her broad administrative and programmatic experiences to bear on the next phase for DEIJ and mentoring activities.

Lees joined MIT in 1994 as a faculty member in MIT’s Koch Institute (then the Center for Cancer Research) and Department of Biology. Her research focuses on regulators that control cellular proliferation, terminal differentiation, and stemness — functions that are frequently deregulated in tumor cells. She dissects the role of these proteins in normal cell biology and development, and establish how their deregulation contributes to tumor development and metastasis.

Since 2000, she has served on the Department of Biology’s graduate program committee, and played a major role in expanding the diversity of the graduate student population. Lees also serves on DEIJ committees in her home department, as well as at the Koch Institute.

With co-chair with Boleslaw Wyslouch, director of the Laboratory for Nuclear Science, Lees led the ReseArch Scientist CAreer LadderS (RASCALS) committee tasked to evaluate career trajectories for research staff in the School of Science and make recommendations to recruit and retain talented staff, rewarding them for their contributions to the school’s research enterprise.

“Jackie is a powerhouse in translational research, demonstrating how fundamental work at the lab bench is critical for making progress at the patient bedside,” says Nergis Mavalvala, dean of the School of Science. “With Jackie’s dedicated and thoughtful partnership, we can continue to lead in basic research and develop the recruitment, retention, and mentoring and necessary to support our community.”

Saxe will join Lees in supporting and developing programming across the school that could also provide direction more broadly at the Institute.

“Rebecca is an outstanding researcher in social cognition and a dedicated educator — someone who wants our students not only to learn, but to thrive,” says Mavalvala. “I am grateful that Rebecca will join the dean’s leadership team and bring her mentorship and leadership skills to enhance the school.”

For example, in collaboration with former department head James DiCarlo, the BCS department has focused on faculty mentorship of graduate students; and, in collaboration with Professor Mark Bear, the department developed postdoc salary and benefit standards. Both initiatives have become models at MIT.

With colleague Laura Schulz, Saxe also served as co-chair of the Committee on Medical Leave and Hospitalizations (CMLH), which outlined ways to enhance MIT’s current leave and hospitalization procedures and policies for undergraduate and graduate students. Saxe was also awarded MIT’s Committed to Caring award for excellence in graduate student mentorship, as well as the School of Science’s award for excellence in undergraduate teaching.

In her research, Saxe studies human social cognition, using a combination of behavioral testing and brain imaging technologies. She is best known for her work on brain regions specialized for abstract concepts, such as “theory of mind” tasks that involve understanding the mental states of other people. Her TED Talk, “How we read each other’s minds” has been viewed more than 3 million times. She also studies the development of the human brain during early infancy.

She obtained her PhD from MIT and was a Harvard University junior fellow before joining the MIT faculty in 2006. In 2014, the National Academy of Sciences named her one of two recipients of the Troland Award for investigators age 40 or younger “to recognize unusual achievement and further empirical research in psychology regarding the relationships of consciousness and the physical world.” In 2020, Saxe was named a John Simon Guggenheim Foundation Fellow.

Saxe and Lees will also work closely with Kuheli Dutt, newly hired assistant dean for diversity, equity, and inclusion, and other members of the dean’s science council on school-level initiatives and strategy.

“I’m so grateful that Rebecca and Jackie have agreed to take on these new roles,” Mavalvala says. “And I’m super excited to work with these outstanding thought partners as we tackle the many puzzles that I come across as dean.”

International Dyslexia Association recognizes John Gabrieli with highest honor

by Julie Pryor |

Cognitive neuroscientist John Gabrieli has been named the 2021 winner of the Samuel Torrey Orton Award, the International Dyslexia Association’s highest honor. The award recognizes achievements of leading researchers and practitioners in the dyslexia field, as well as those of individuals with dyslexia who exhibit leadership and serve as role models in their communities.

“I am grateful to the International Dyslexia Association for this recognition,” said Gabrieli, who is the Grover Hermann Professor of Health Sciences and Technology, a professor of brain and cognitive sciences, and a member of MIT’s McGovern Institute for Brain Research. “The association has been such an advocate for individuals and their families who struggle with dyslexia, and has also been such a champion for the relevant science. I am humbled to join the company of previous recipients of this award who have done so much to help us understand dyslexia and how individuals with dyslexia can be supported to flourish in their growth and development.”

Gabrieli, who is also the director of MIT’s Athinoula A. Martinos Imaging Center, uses neuroimaging and behavioral tests to understand how the human brain powers learning, thinking, and feeling.  For the last two decades, Gabrieli has sought to unravel the neuroscience behind learning and reading disabilities and, ultimately, convert that understanding into new and better education interventions—a sort of translational medicine for the classroom.

“We want to get every kid to be an adequate reader by the end of the third grade,” Gabrieli says. “That’s the ultimate goal: to help all children become learners.”

In March of 2018, Gabrieli and the MIT Integrated Learning Initiative—MITili, which he also directs—announced a $30 million-dollar grant from the Chan Zuckerberg Initiative for a collaboration between MIT, the Harvard Graduate School of Education, and Florida State University. This partnership, called “Reach Every Reader” aims to make significant progress on the crisis in early literacy – including tools to identify children at risk for dyslexia and other learning disabilities before they even learn to read.

“John is especially deserving of this award,” says Hugh Catts, Gabrieli’s colleague at Reach Every Reader. Catts is a professor and director of the School of Communications Science and Disorders at Florida State University. “His work has been seminal to our understanding of the neural basis of learning and learning difficulties such as dyslexia. He has been a strong advocate for individuals with dyslexia and a mentor to leading experts in the field,” says Catts, who is also received the Orton Award in 2008.

“It’s a richly deserved honor,”says Sanjay Sarma, the Fred Fort Flowers (1941) and Daniel Fort Flowers (1941) Professor of Mechanical Engineering at MIT. “John’s research is a cornerstone of MIT’s efforts to make education more equitable and accessible for all. His contributions to learning science inform so much of what we do, and his advocacy continues to raise public awareness of dyslexia and helps us better reach the dyslexic community through literacy initiatives such as Reach Every Reader. We’re so pleased that his work has been recognized with the Samuel Torrey Orton Award,” says Sarma, who is also Vice President for Open Learning at MIT.

Gabrieli will deliver the Samuel Torrey Orton and Joan Lyday Orton Memorial Lecture this fall in North Carolina as part of the 2021 International Dyslexia Association’s Annual Reading, Literacy and Learning Conference.

 

 

MIT Technology Review names McGovern Fellows top innovators under 35

by Julie Pryor |

McGovern Institute Fellows Omar Abudayyeh and Jonathan Gootenberg have both been named to MIT Technology Review’s annual list of exceptional innovators under the age of 35. The annual list recognizes “exceptionally talented technologists whose work has great potential to transform the world.”

Abudayyeh was named to the 2020 list for developing a CRISPR-based test for COVID-19; a diagnostic technology that now has potential to rapidly and economically detect a wide variety of diseases.

This year, Gootenberg is being recognized for his work with CRISPR gene editing technologies to develop a cellular engineering “toolkit” that will help scientists better understand — and treat — diseases that affect millions worldwide.

“I’m honored that our lab’s work on molecular tools for cellular engineering is being recognized for its potential impact on diagnostics and therapeutics for patients.” — Jonathan Gootenberg

During their time in the Zhang lab, Abudayyeh and Gootenberg engineered new genome editing tools based on enzymes that they and others discovered from scanning bacterial CRISPR systems. In 2018, Gootenberg and Abudayyeh became the first members of the McGovern Institute Fellows program, which supports the transition to independent research for exceptional recent PhD graduates.

“It’s exciting that alternative uses of CRISPR beyond gene editing are being recognized, including for sensing and diagnosing diverse disease states and that certain CRISPR-based COVID-19 diagnostic assays already authorized for patient use,” says Abudayyeh.

CRISPR-based COVID-19 test using paper strips. Photo: Broad Institute

“Omar and Jonathan’s combination of basic discovery and synthetic biology continues to deliver ever more powerful tools for probing and controlling cell activity,” says McGovern Institute Director Robert Desimone. “Such tools are key to the immense challenge of understanding brain function, and treating dysfunction, the goal of the McGovern Institute.”

Now Abudayyeh and Gootenberg is expanding the boundaries of cellular engineering tools, to encompass not only genome editing but also transcriptome control and cell-state sensing — powerful technologies that can change or correct how cells behave without permanently changing their genome. Just as CRISPR has helped decode the role of genes in disease and provided a method for changing gene sequences, the pair’s cellular engineering tools reveal how cells in the body transform in response to disease and provide new means of curing disease. It is the potential of these tools to usher in a new era of cellular discoveries and treatments that caught the attention of the editors at MIT Technology Review.

“We get more than 500 nominations for the list every year, and getting that list down to 35—a task not only for the editors at MIT Technology Review but also for our 30+ judges—is one of the hardest things we do each year,” says Tim Maher, Managing Editor of MIT Technology Review. “We love the way the final list always shows what a wide variety of people there are, all around the world, working on creative solutions to some of humanity’s hardest problems.”

Gootenberg and Abudayyeh continue to work together to build a comprehensive toolkit to both understand and engineer human cells. Gootenberg and his fellow honorees will be featured at the upcoming EmTech MIT conference, MIT Technology Review’s annual flagship event that offers a perspective on the most significant developments of the year, with a focus on understanding their potential business and societal impact. EmTech MIT will be held online September 28-30, 2021.

Nine MIT students awarded 2021 Paul and Daisy Soros Fellowships for New Americans

by Julia Mongo | Office of Distinguished Fellowships |

An MIT senior and eight MIT graduate students are among the 30 recipients of this year’s P.D. Soros Fellowships for New Americans. In addition to senior Fiona Chen, MIT’s newest Soros winners include graduate students Aziza Almanakly, Alaleh Azhir, Brian Y. Chang PhD ’18, James Diao, Charlie ChangWon Lee, Archana Podury, Ashwin Sah ’20, and Enrique Toloza. Six of the recipients are enrolled at the Harvard-MIT Program in Health Sciences and Technology.

P.D. Soros Fellows receive up to $90,000 to fund their graduate studies and join a lifelong community of new Americans from different backgrounds and fields. The 2021 class was selected from a pool of 2,445 applicants, marking the most competitive year in the fellowship’s history.

The Paul & Daisy Soros Fellowships for New Americans program honors the contributions of immigrants and children of immigrants to the United States. As Fiona Chen says, “Being a new American has required consistent confrontation with the struggles that immigrants and racial minorities face in the U.S. today. It has meant frequent difficulties with finding security and comfort in new contexts. But it has also meant continual growth in learning to love the parts of myself — the way I look; the things that my family and I value — that have marked me as different, or as an outsider.”

Students interested in applying to the P.D. Soros fellowship should contact Kim Benard, assistant dean of distinguished fellowships in Career Advising and Professional Development.

Aziza Almanakly

Aziza Almanakly, a PhD student in electrical engineering and computer science, researches microwave quantum optics with superconducting qubits for quantum communication under Professor William Oliver in the Department of Physics. Almanakly’s career goal is to engineer multi-qubit systems that push boundaries in quantum technology.

Born and raised in northern New Jersey, Almanakly is the daughter of Syrian immigrants who came to the United States in the early 1990s in pursuit of academic opportunities. As the civil war in Syria grew dire, more of her relatives sought asylum in the U.S. Almanakly grew up around extended family who built a new version of their Syrian home in New Jersey.

Following in the footsteps of her mathematically minded father, Almanakly studied electrical engineering at The Cooper Union for the Advancement of Science and Art. She also pursued research opportunities in experimental quantum computing at Princeton University, the City University of New York, New York University, and Caltech.

Almanakly recognizes the importance of strong mentorship in diversifying engineering. She uses her unique experience as a New American and female engineer to encourage students from underrepresented backgrounds to enter STEM fields.

Alaleh Azhir

Alaleh Azhir grew up in Iran, where she pursued her passion for mathematics. She immigrated with her mother to the United States at age 14. Determined to overcome strict gender roles she had witnessed for women, Azhir is dedicated to improving health care for them.

Azhir graduated from Johns Hopkins University in 2019 with a perfect GPA as a triple major in biomedical engineering, computer science, and applied mathematics and statistics. A Rhodes and Barry Goldwater Scholar, she has developed many novel tools for visualization and analysis of genomics data at Johns Hopkins University, Harvard University, MIT, the National Institutes of Health, and laboratories in Switzerland.

After completing a master’s in statistical science at Oxford University, Azhir began her MD studies in the Harvard-MIT Program in Health Sciences and Technology. Her thesis focuses on the role of X and Y sex chromosomes on disease manifestations. Through medical training, she aims to build further computational tools specifically for preventive care for women. She has also founded and directs the nonprofit organization, Frappa, aimed at mentoring women living in Iran and helping them to immigrate abroad through the graduate school application process.

Brian Y. Chang PhD ’18

Born in Johnson City, New York, Brian Y. Chang PhD ’18 is the son of immigrants from the Shanghai municipality and Shandong Province in China. He pursued undergraduate and master’s degrees in mechanical engineering at Carnegie Mellon University, graduating in a combined four years with honors.

In 2018, Chang completed a PhD in medical engineering at MIT. Under the mentorship of Professor Elazer Edelman, Chang developed methods that make advanced cardiac technologies more accessible. The resulting approaches are used in hospitals around the world. Chang has published extensively and holds five patents.

With the goal of harnessing the power of engineering to improve patient care, Chang co-founded X-COR Therapeutics, a seed-funded medical device startup developing a more accessible treatment for lung failure with the potential to support patients with severe Covid-19 and chronic obstructive pulmonary disease.

After spending time in the hospital connecting with patients and teaching cardiovascular pathophysiology to medical students, Chang decided to attend medical school. He is currently a medical student in the Harvard-MIT Program in Health Sciences and Technology. Chang hopes to advance health care through medical device innovation and education as a future physician-scientist, entrepreneur, and educator.

Fiona Chen

MIT senior Fiona Chen was born in Cedar Park, Texas, the daughter of immigrants from China. Witnessing how her own and many other immigrant families faced significant difficulties finding work and financial stability sparked her interest in learning about poverty and economic inequality.

At MIT, Chen has pursued degrees in economics and mathematics. Her economics research projects have examined important policy issues — social isolation among students, global development and poverty, universal health-care systems, and the role of technology in shaping the labor market.

An active member of the MIT community, Chen has served as the officer on governance and officer on policy of the Undergraduate Association, MIT’s student government; the opinion editor of The Tech student newspaper; the undergraduate representative of several Institute-wide committees, including MIT’s Corporation Joint Advisory Committee; and one of the founding members of MIT Students Against War. In each of these roles, she has worked to advocate for policies to support underrepresented groups at MIT.

As a Soros fellow, Chen will pursue a PhD in economics to deepen her understanding of economic policy. Her ultimate goal is to become a professor who researches poverty and economic inequality, and applies her findings to craft policy solutions.

James Diao

James Diao graduated from Yale University with degrees in statistics and biochemistry and is currently a medical student at the Harvard-MIT Program in Health Sciences and Technology. He aspires to give voice to patient perspectives in the development and evaluation of health-care technology.

Diao grew up in Houston’s Chinatown, and spent summers with his extended family in Jiangxian. Diao’s family later moved to Fort Bend, Texas, where he found a pediatric oncologist mentor who introduced him to the wonders of modern molecular biology.

Diao’s interests include the responsible development of technology. At Apple, he led projects to validate wearable health features in diverse populations; at PathAI, he built deep learning models to broaden access to pathologist services; at Yale, where he worked on standardizing analyses of exRNA biomarkers; and at Harvard, he studied the impacts of clinical guidelines on marginalized groups.

Diao’s lead author research in the New England Journal of Medicine and JAMA systematically compared race-based and race-free equations for kidney function, and demonstrated that up to 1 million Black Americans may receive unequal kidney care due to their race. He has also published articles on machine learning and precision medicine.

Charlie ChangWon Lee

Born in Seoul, South Korea, Charlie ChangWon Lee was 10 when his family immigrated to the United States and settled in Palisades Park, New Jersey. The stress of his parents’ lack of health coverage ignited Lee’s determination to study the reasons for the high cost of health care in the U.S. and learn how to care for uninsured families like his own.

Lee graduated summa cum laude in integrative biology from Harvard College, winning the Hoopes Prize for his thesis on the therapeutic potential of human gut microbes. Lee’s research on novel therapies led him to question how newly approved, and expensive, medications could reach more patients.

At the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women’s Hospital, Lee studied policy issues involving pharmaceutical drug pricing, drug development, and medication use and safety. His articles have appeared in JAMA, Health Affairs, and Mayo Clinic Proceedings.

As a first-year medical student at the Harvard-MIT Health Sciences and Technology program, Lee is investigating policies to incentivize vaccine and biosimilar drug development. He hopes to find avenues to bridge science and policy and translate medical innovations into accessible, affordable therapies.

Archana Podury

The daughter of Indian immigrants, Archana Podury was born in Mountain View, California. As an undergraduate at Cornell University, she studied the neural circuits underlying motor learning. Her growing interest in whole-brain dynamics led her to the Princeton Neuroscience Institute and Neuralink, where she discovered how brain-machine interfaces could be used to understand diffuse networks in the brain.

While studying neural circuits, Podury worked at a syringe exchange in Ithaca, New York, where she witnessed firsthand the mechanics of court-based drug rehabilitation. Now, as an MD student in the Harvard-MIT Health Sciences and Technology program, Podury is interested in combining computational and social approaches to neuropsychiatric disease.

In the Boyden Lab at the MIT McGovern Institute for Brain Research, Podury is developing human brain organoid models to better characterize circuit dysfunction in neurodevelopmental disorders. Concurrently, her work in the Dhand Lab at Brigham and Women’s Hospital applies network science tools to understand how patients’ social environments influence their health outcomes following acute neurological injury.

Podury hopes that focusing on both neural and social networks can lead toward a more comprehensive, and compassionate, approach to health and disease.

Ashwin Sah ’20

Ashwin Sah ’20 was born and raised in Portland, Oregon, the son of Indian immigrants. He developed a passion for mathematics research as an undergraduate at MIT, where he conducted research under Professor Yufei Zhao, as well as at the Duluth and Emory REU (Research Experience for Undergraduates) programs.

Sah has given talks on his work at multiple professional venues. His undergraduate research in varied areas of combinatorics and discrete mathematics culminated in the Barry Goldwater Scholarship and the Frank and Brennie Morgan Prize for Outstanding Research in Mathematics by an Undergraduate Student. Additionally, his work on diagonal Ramsey numbers was recently featured in Quanta Magazine.

Beyond research, Sah has pursued opportunities to give back to the math community, helping to organize or grade competitions such as the Harvard-MIT Mathematics Tournament and the USA Mathematical Olympiad. He has also been a grader at the Mathematical Olympiad Program, a camp for talented high-school students in the United States, and an instructor for the Monsoon Math Camp, a virtual program aimed at teaching higher mathematics to high school students in India.

Sah is currently a PhD student in mathematics at MIT, where he continues to work with Zhao.

Enrique Toloza

Enrique Toloza was born in Los Angeles, California, the child of two immigrants: one from Colombia who came to the United States for a PhD and the other from the Philippines who grew up in California and went on to medical school. Their literal marriage of science and medicine inspired Toloza to become a physician-scientist.

Toloza majored in physics and Spanish literature at the University of North Carolina at Chapel Hill. He eventually settled on an interest in theoretical neuroscience after a summer research internship at MIT and completing an honors thesis on noninvasive brain stimulation.

After college, Toloza joined Professor Mark Harnett’s laboratory at MIT for a year. He went on to enroll in the Harvard-MIT MD/PhD program, studying within the Health Sciences and Technology MD curriculum at Harvard and the PhD program at MIT. For his PhD, Toloza rejoined Harnett to conduct research on the biophysics of dendritic integration and the contribution of dendrites to cortical computations in the brain.

Toloza is passionate about expanding health care access to immigrant populations. In college, he led the interpreting team at the University of North Carolina at Chapel Hill’s student-run health clinic; at Harvard Medical School, he has worked with Spanish-speaking patients as a student clinician.

Four MIT scientists honored with 2021 National Academy of Sciences awards

Anne Trafton |

Four MIT scientists are among the 20 recipients of the 2021 Academy Honors for major contributions to science, the National Academy of Sciences (NAS) announced at its annual meeting. The individuals are recognized for their “extraordinary scientific achievements in a wide range of fields spanning the physical, biological, social, and medical sciences.”

The awards recognize: Pablo Jarillo-Herrero, for contributions to the fields of nanoscience and nanotechnology through his discovery of correlated insulator behavior and unconventional superconductivity in magic-angle graphene superlattices; Aviv Regev, for using interdisciplinary information or techniques to solve a contemporary challenge; Susan Solomon, for contributions to understanding and communicating the causes of ozone depletion and climate change; and Feng Zhang, for pioneering achievements developing CRISPR tools with the potential to diagnose and treat disease.

Pablo Jarillo-Herrero: Award for Scientific Discovery

Pablo Jarillo-Herrero, a Cecil and Ida Green Professor of Physics, is the recipient of the NAS Award for Scientific Discovery for his pioneering developments in nanoscience and nanotechnology, which is presented to scientists in the fields of astronomy, materials science, or physics. His findings expand nanoscience by demonstrating for the first time that orientation can be used to dramatically control nanomaterial properties and to design new nanomaterials. This work lays the groundwork for developing a whole new family of 2D materials and has had a transformative impact on the field and on condensed-matter physics.

The biannual award recognizes “an accomplishment or discovery in basic research, achieved within the previous five years, that is expected to have a significant impact on one or more of the following fields: astronomy, biochemistry, biophysics, chemistry, materials science, or physics.”

In 2018, his research group discovered that by rotating two layers of graphene relative to each other by a magic angle, the bilayer material can be turned from a metal into an electrical insulator or even a superconductor. This discovery has fostered new theoretical and experimental research, inspiring the interest of technologists in nanoelectronics. The result is a new field in condensed-matter physics that has the potential to result in materials that conduct electricity without resistance at room temperature.

Aviv Regev: James Prize in Science and Technology Integration

Aviv Regev, who is a professor of biology, a core member of the Broad Institute of Harvard and MIT, a member of the Koch Institute, and a Howard Hughes Medical Institute investigator has been selected for the inaugural James Prize in Science and Technology Integration, along with Harvard Medical School Professor Allon Kelin, for “their concurrent development of now widely adopted massively parallel single-cell genomics to interrogate the gene expression profiles that define, at the level of individual cells, the distinct cell types in metazoan tissues, their developmental trajectories, and disease states, which integrated tools from molecular biology, engineering, statistics, and computer science.”

The prize recognizes individuals “who are able to adopt or adapt information or techniques from outside their fields” to “solve a major contemporary challenge not addressable from a single disciplinary perspective.”

Regev is credited with forging new ways to unite the disciplines of biology, computational science, and engineering as a pioneer in the field of single-cell biology, including developing some of its core experimental and analysis tools, and their application to discover cell types, states, programs, environmental responses, development, tissue locations, and regulatory circuits, and deploying these to assemble cellular atlases of the human body that illuminate mechanisms of disease with remarkable fidelity.

Susan Solomon: Award for Chemistry in Service to Society

Susan Solomon, the Lee and Geraldine Martin Professor of Environmental Studies in the Department of Earth, Atmospheric and Planetary Sciences who holds a secondary appointment in the Department of Chemistry, is the recipient of the Award for Chemistry in Service to Society for “influential and incisive application of atmospheric chemistry to understand our most critical environmental issues — ozone layer depletion and climate change — and for her effective communication of environmental science to leaders to facilitate policy changes.”

The award is given biannually for “contributions to chemistry, either in fundamental science or its application, that clearly satisfy a societal need.”

Solomon is globally recognized as a leader in atmospheric science, notably for her insights in explaining the cause of the Antarctic ozone “hole.” She and her colleagues have made important contributions to understanding chemistry-climate coupling, including pioneering research on the irreversibility of global warming linked to anthropogenic carbon dioxide emissions, and on the influence of the ozone hole on the climate of the southern hemisphere.

Her work has had an enormous effect on policy and society, including the transition away from ozone-depleting substances and to environmentally benign chemicals. The work set the stage for the Paris Agreement on climate, and she continues to educate policymakers, the public, and the next generation of scientists.

Feng Zhang: Richard Lounsbery Award

Feng Zhang, who is the James and Patricia Poitras Professor of Neuroscience at MIT, an investigator at the McGovern Institute for Brain Research and the Howard Hughes Medical Institute, a professor of brain and cognitive sciences and biological engineering at MIT, and a core member of the Broad Institute of MIT and Harvard, is the recipient of the Richard Lounsbery Award for pioneering CRISPR-mediated genome editing.

The award recognizes “extraordinary scientific achievement in biology and medicine” as well as stimulating research and encouraging reciprocal scientific exchanges between the United States and France.

Zhang continues to lead the field through the discovery of novel CRISPR systems and their development as molecular tools with the potential to diagnose and treat disease, such as disorders affecting the nervous system. His contributions in genome engineering, as well as his earlier work developing optogenetics, are enabling a deeper understanding of behavioral neural circuits and advances in gene therapy for treating disease.

In addition, Zhang has championed the open sharing of the technologies he has developed through extensive resource sharing. The tools from his lab are being used by thousands of scientists around the world to accelerate research in nearly every field of the life sciences. Even as biomedical researchers around the world adopt Zhang’s discoveries and his tools enter the clinic to treat genetic diseases, he continues to innovate and develop new technologies to advance science.

The National Academy of Sciences is a private, nonprofit society of distinguished scholars, established in 1863 by the U.S. Congress. The NAS is charged with providing independent, objective advice to the nation on matters related to science and technology as well as encouraging education and research, recognize outstanding contributions to knowledge, and increasing public understanding in matters of science, engineering, and medicine. Winners received their awards, which include a monetary prize, during a virtual ceremony at the 158th NAS Annual Meeting.

This story is a modified compilation from several National Academy of Sciences press releases.

Two MIT Brain and Cognitive Sciences faculty members earn funding from the G. Harold and Leila Y. Mathers Foundation

by David Orenstein |

Two MIT neuroscientists have received grants from the G. Harold and Leila Y. Mathers Foundation to screen for genes that could help brain cells withstand Parkinson’s disease and to map how gene expression changes in the brain in response to drugs of abuse.

Myriam Heiman, an associate professor in MIT’s Department of Brain and Cognitive Sciences and a core member of the Picower Institute for Learning and Memory and the Broad Institute of MIT and Harvard, and Alan Jasanoff, who is also a professor in biological engineering, brain and cognitive sciences, nuclear science and engineering and an associate investigator at the McGovern Institute for Brain Research, each received three-year awards that formally begin January 1, 2021.

Jasanoff, who also directs MIT’s Center for Neurobiological Engineering, is known for developing sensors that monitor molecular hallmarks of neural activity in the living brain, in real time, via noninvasive MRI brain scanning. One of the MRI-detectable sensors that he has developed is for dopamine, a neuromodulator that is key to learning what behaviors and contexts lead to reward. Addictive drugs artificially drive dopamine release, thereby hijacking the brain’s reward prediction system. Studies have shown that dopamine and drugs of abuse activate gene transcription in specific brain regions, and that this gene expression changes as animals are repeatedly exposed to drugs. Despite the important implications of these neuroplastic changes for the process of addiction, in which drug-seeking behaviors become compulsive, there are no effective tools available to measure gene expression across the brain in real time.

Cerebral vasculature in mouse brain. The Jasanoff lab hopes to develop a method for mapping gene expression the brain with related labeling characteristics .
Image: Alan Jasanoff

With the new Mathers funding, Jasanoff is developing new MRI-detectable sensors for gene expression. With these cutting-edge tools, Jasanoff proposes to make an activity atlas of how the brain responds to drugs of abuse, both upon initial exposure and over repeated doses that simulate the experiences of drug addicted individuals.

“Our studies will relate drug-induced brain activity to longer term changes that reshape the brain in addiction,” says Jasanoff. “We hope these studies will suggest new biomarkers or treatments.”

Dopamine-producing neurons in a brain region called the substantia nigra are known to be especially vulnerable to dying in Parkinson’s disease, leading to the severe motor difficulties experienced during the progression of the incurable, chronic neurodegenerative disorder. The field knows little about what puts specific cells at such dire risk, or what molecular mechanisms might help them resist the disease. In her research on Huntington’s disease, another incurable neurodegenerative disorder in which a specific neuron population in the striatum is especially vulnerable, Heiman has been able to use an innovative method her lab pioneered to discover genes whose expression promotes neuron survival, yielding potential new drug targets. The technique involves conducting an unbiased screen in which her lab knocks out each of the 22,000 genes expressed in the mouse brain one by one in neurons in disease model mice and healthy controls. The technique allows her to determine which genes, when missing, contribute to neuron death amid disease and therefore which genes are particularly needed for survival. The products of those genes can then be evaluated as drug targets. With the new Mathers award, Heiman plans to apply the method to study Parkinson’s disease.

An immunofluorescence image taken in a brain region called the substantia nigra (SN) highlights tyrosine hydroxylase, a protein expressed by dopamine neurons. This type of neuron in the SN is especially vulnerable to neurodegeneration in Parkinson’s disease. Image: Preston Ge/Heiman Lab

“There is currently no molecular explanation for the brain cell loss seen in Parkinson’s disease or a cure for this devastating disease,” Heiman said. “This award will allow us to perform unbiased, genome-wide genetic screens in the brains of mouse models of Parkinson’s disease, probing for genes that allow brain cells to survive the effects of cellular perturbations associated with Parkinson’s disease. I’m extremely grateful for this generous support and recognition of our work from the Mathers Foundation, and hope that our study will elucidate new therapeutic targets for the treatment and even prevention of Parkinson’s disease.”